I-STOP: a mobile health program to help people with HIV quit smoking
Official title: Implementing Sustainable mobile health Technology to Optimize smoking cessation Program for people with HIV (I-STOP)
Funded at University of Oklahoma Hlth Sciences Ctr · NIH-11535367 · Data updated 2026-11-12
A smartphone-based program designed to help people with HIV quit smoking in a sustainable, affordable way.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project start | August 12, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $111,521 |
| NIH project number | 3U01CA294811-03S1 |
| Project ID | NIH-11535367 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults living with HIV who smoke and receive care in diverse US settings, especially underserved or low-resource clinics.
✕Less likely to help
Patients who do not smoke or prefer not to use mobile health tools may see limited direct benefit.
What this research studies
This project aims to implement a scalable, automated mobile health smoking-cessation program tailored for people with HIV, using interactive and personalized app content. It builds on proven strategies like Ask-Advise-Connect to identify smokers, advise quit attempts, and connect patients to treatment. The goal is to make tobacco-cessation support available in diverse HIV care settings, including rural and underserved communities, and to study how to sustain these practices over time. The study will link patients who smoke to evidence-based cessation resources and track how well the program works in real-world clinics.
Why it matters
Potential benefit: If successful, the program could help more people with HIV quit smoking, improving cancer outcomes and overall health.
How similar studies have gone: Previous US studies showed that AAC-like approaches and mHealth tools can support cessation, and this work extends those findings to new clinical settings.
Where this research is happening
-
University of Oklahoma Hlth Sciences Ctr
Oklahoma City, United States Active
Researchers
- Principal investigator: Bui, Thanh C. — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Bui, Thanh C.
Related research
Other NIH-funded projects on the same topics.
-
Social stress and smoking: why disadvantaged young adults struggle to quit
This grant looks at how daily social stress affects if and when disadvantaged young adults who smoke can quit and stay quit.
-
Smoking cessation help for people with HIV in South Africa
A program is being tested to help people living with HIV in South Africa quit smoking in ways that fit low-resource clinics and show good value.
-
Mobile tools to understand how sleep affects quitting smoking
This project uses a smartphone to track sleep and smoking in lower-income adults trying to quit to find how sleep patterns relate to staying smoke-free.
-
Integrated approach to lung screening and quitting for African Americans
A multi-level program aims to boost LDCT lung cancer screening uptake and help African American smokers quit, with support from a comprehensive community-focused plan.
-
Peer-led smoking-cessation program for public housing residents
A peer-led program with eight group sessions plus nicotine replacement therapy is tested on adults living in public housing to help them quit smoking.
-
Real-world use of quit aids in US adults
This project studies how well different quitting aids work in everyday life for adults in the United States who smoke.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.